Deep vein thrombosis: a clinical review
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Deep vein thrombosis (DVT) is the formation of blood clots (thrombi) in the deep veins. It commonly affects the deep leg veins (such as the calf veins, femoral vein, or popliteal vein) or the deep veins of the pelvis. It is a potentially dangerous condition that can lead to preventable morbidity and mortality. AIM: To present an update on the causes and management of DVT. METHODS: A review of publications obtained from Medline search, medical libraries, and Google. RESULTS: DVT affects 0.1% of persons per year. It is predominantly a disease of the elderly and has a slight male preponderance. The approach to making a diagnosis currently involves an algorithm combining pretest probability, D-dimer testing, and compression ultrasonography. This will guide further investigations if necessary. Prophylaxis is both mechanical and pharmacological. The goals of treatment are to prevent extension of thrombi, pulmonary embolism, recurrence of thrombi, and the development of complications such as pulmonary hypertension and post-thrombotic syndrome. CONCLUSION: DVT is a potentially dangerous condition with a myriad of risk factors. Prophylaxis is very important and can be mechanical and pharmacological. The mainstay of treatment is anticoagulant therapy. Low-molecular-weight heparin, unfractionated heparin, and vitamin K antagonists have been the treatment of choice. Currently anticoagulants specifically targeting components of the common pathway have been recommended for prophylaxis. These include fondaparinux, a selective indirect factor Xa inhibitor and the new oral selective direct thrombin inhibitors (dabigatran) and selective factor Xa inhibitors (rivaroxaban and apixaban). Others are currently undergoing trials. Thrombolytics and vena caval filters are very rarely indicated in special circumstances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.585 · Cited by 2,660
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534 · cited 1×
“Long-term anticoagulant therapy with LMWH is more effective than warfarin at preventing recurrent venous thrombosis in cancer patients without a statistically significant bleeding risk.(101) The duration of anticoagulation depends on whether the patient has a first episode of DVT, ongoing risk factors for VTE disease,…”
Warkentin, T. E., Levine, M. N., Hirsh, J., Horsewood, P., Roberts, R. S., Gent, M., & Kelton, J. G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322003 · Cited by 2,328 · cited 4×
“78 It has a far greater effect on inhibition of factor Xa and a lesser effect on antithrombin III by inhibiting thrombin to a lesser extent than UFH.”
InfluentialAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380701 · Cited by 1,702
Risk Factors for Venous Thromboembolism
Anderson, F. A., & Spencer, F. A. (2003) · Circulation · doi:10.1161/01.cir.0000078469.07362.e6 · Cited by 1,652
Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
Wells, P. S., Anderson, D. R., Rodger, M., Forgie, M., Kearon, C., Dreyer, J., Kovacs, G., Mitchell, M., Lewandowski, B., & Kovacs, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023153 · Cited by 1,552 · cited 1×
“The combination of clinical risk stratification and a D-dimer test can exclude VTE in more than 25% of patients presenting with symptoms suggestive of VTE without the need for additional investigations.(39) Even in patients with clinically suspected recurrent DVT, this combination (clinical evaluation and D-dimer) has…”
Katayama, H., Yamaguchi, K., Kozuka, T., Takashima, T., Seez, P., & Matsuura, K. (1990) · Radiology · doi:10.1148/radiology.175.3.2343107 · Cited by 1,474
Incidence and mortality of venous thrombosis: a population‐based study
NÆSS, I. A., CHRISTIANSEN, S. C., ROMUNDSTAD, P., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTRØM, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02450.x · Cited by 1,413
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314
Value of assessment of pretest probability of deep-vein thrombosis in clinical management
Wells, P. S., Anderson, D. R., Bormanis, J., Guy, F., Mitchell, M., Gray, L., Clement, C., Robinson, K. S., & Lewandowski, B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08140-3 · Cited by 1,229
Natural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048
Andrew, M., David, M., Adams, M., Ali, K., Anderson, R., Barnard, D., Bernstein, M., Brisson, L., Cairney, B., & DeSai, D. (1994) · Blood · doi:10.1182/blood.v83.5.1251.1251 · Cited by 1,038 · cited 1×
“3 per 10,000 hospital admissions have been reported in Caucasian studies.(6,7) This low incidence may be due to decreased capacity to generate thrombin, increased capacity of alpha-2-macroglobulin to inhibit thrombin, and enhanced antithrombin potential of vessel walls.”
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., & Raschke, R. (2004) · Chest · doi:10.1378/chest.126.3_suppl.188s · Cited by 971
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Accuracy of clinical assessment of deep-vein thrombosis
Wells, P., Hirsh, J., Anderson, D., Lensing, A. A., Foster, G., Kearon, C., Weitz, J., D'Ovidio, R., Cogo, A., Prandoni, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92535-x · Cited by 798 · cited 1×
“The high-probability group has an 85% risk of DVT, the moderate-probability group a 33% risk, and the low-probability group a 5% risk.(36) However, in a later study, Wells and colleagues further streamlined the diagnostic process by stratifying patients into two risk categories: “DVT unlikely” if the clinical score is…”
Patrono, C., Baigent, C., Hirsh, J., & Roth, G. (2008) · Chest · doi:10.1378/chest.08-0672 · Cited by 748
Roentgen Diagnosis of Venous Thrombosis in the Leg
Rabinov, K. (1972) · Archives of Surgery · doi:10.1001/archsurg.1972.04180020014004 · Cited by 740 · cited 2×
“A large volume of Omnipaque diluted with normal saline results in better deep venous filling and improved image quality.(56) The most reliable cardinal sign for the diagnosis of phlebothrombosis using venogram is a constant intraluminal filling defect evident in two or more views.”
Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands
van Ommen, C. H., Heijboer, H., Büller, H. R., Hirasing, R. A., Heijmans, H. S. A., & Peters, M. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.118192 · Cited by 696
Noninvasive Diagnosis of Deep Venous Thrombosis
Kearon, C., Julian, J. A., Math, M., Newman, T. E., & Ginsberg, J. S. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-8-199804150-00011 · Cited by 690
Basu, D., Gallus, A., Hirsh, J., & Cade, J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208172870703 · Cited by 661 · cited 1×
“…efficacy of treatment with heparin largely depends on the ability to achieve a critical therapeutic ratio within the first 24 hours of treatment, 97,98 ie, achieving an activated partial thromboplastin time (aPTT) that is 1.5 times the mean of control value or the upper limit of normal aPTT…”
InfluentialUse of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., & Hirsh, J. (1995) · Chest · doi:10.1378/chest.108.4_supplement.305s · Cited by 657
Hirsh, J., & Hoak, J. (1996) · Circulation · doi:10.1161/01.cir.93.12.2212 · Cited by 635
Sandler, D. A., & Martin, J. F. (1989) · Journal of the Royal Society of Medicine · doi:10.1177/014107688908200407 · Cited by 617 · cited 1×
“Though regarded mainly as a surgical complication, most symptomatic VTE events and fatal PE occur in medical patients.(15)”
Oral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579 · cited 11×
“These assays differ in sensitivity, specificity, likelihood ratio, and variability among patients with suspected VTE.”
InfluentialHirsh, J., Dalen, J. E., Deykin, D., & Toller, L. (1992) · Chest · doi:10.1378/chest.102.4_supplement.337s · Cited by 558
Kearon, C., Ginsberg, J. S., & Hirsh, J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-12-199812150-00009 · Cited by 489 · cited 1×
“Other criteria for ultrasonographic diagnosis of venous thrombosis include loss of phasic pattern in which flow is defined as continuous, response to valsava or augmentation (Duplex ultrasound), and complete absence of spectral or color Doppler signals from the vein lumen.(53) The other advantages of venous ultrasound…”
The Risk of Recurrent Venous Thromboembolism in Men and Women
Kyrle, P. A., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A., & Eichinger, S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032959 · Cited by 477
Simpson, E. L., Lawrenson, R. A., Nightingale, A. L., & Farmer, R. D. T. (2001) · British Journal of Obstetrics and Gynaecology · doi:10.1016/s0306-5456(00)00004-8 · Cited by 412
Dahl, O., Huo, M., Kurth, A., Hantel, S., Hermansson, K., Schnee, J., Friedman, R., Eriksson, B., & for the RE-NOVATE II Study Group (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-10-0679 · Cited by 401
Hirsh, J., Raschke, C. R., Warkentin, T. E., Dalen, J. E., Deykin, D., & Poller, L. (1995) · Chest · doi:10.1378/chest.108.4_supplement.258s · Cited by 394
Vena caval filters: a comprehensive review
Streiff, M. B. (2000) · Blood · doi:10.1182/blood.v95.12.3669 · Cited by 370 · cited 2×
“Absolute contraindications to anticoagulation include central nervous system (CNS) hemorrhage, overt gastrointestinal bleeding, retroperitoneal hemorrhage, massive hemoptysis, cerebral metastases, massive cerebrovascular accident, CNS trauma, and significant thrombocytopenia (,50,000/ μL).(108) They may be retrievable…”
Elastic compression stockings for prevention of deep vein thrombosis
Sachdeva, A., Dalton, M., Amaragiri, S. V., & Lees, T. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001484.pub2 · Cited by 354
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Weitz, J., Ginsberg, J., Geerts, W., LeClerc, J., Neemeh, J., Powers, P., et al. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649783 · Cited by 353
Stein, P. D., Kayali, F., & Olson, R. E. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.06.021 · Cited by 352 · cited 1×
“The incidence rate is comparatively higher in adolescent females because of pregnancy and use of oral contraceptive agents.(9) Pregnant women have a much higher risk of VTE than nonpregnant women of similar age and the risk has been shown to be higher after cesarian section than after vaginal delivery.”
The Diagnostic Approach to Acute Venous Thromboembolism: Clinical Practice Guideline
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.16030 · Cited by 325 · cited 1×
“Another reliable criterion is an abrupt cutoff of a deep vein, a sign difficult to interpret in patients with previous DVT.(57) It is highly sensitive especially in identifying the location, extent and attachment of a clot and also highly specific.”
Heit, J. A., Petterson, T. M., Farmer, S. A., Bailey, K. R., & Melton, L. J. (2006) · Blood · doi:10.1182/blood.v108.11.1488.1488 · Cited by 319
The origin of deep vein thrombosis: a venographic study
Nicolaides, A. N., Kakkar, V. V., Field, E. S., & Renney, J. T. G. (1971) · The British Journal of Radiology · doi:10.1259/0007-1285-44-525-653 · Cited by 301 · cited 1×
“This is especially true for those that occur following surgery.(16) Though most thrombi begin intraoperatively, some start a few days, weeks, or months after surgery.”
Antithrombotic and Thrombolytic Therapy
Hirsh, J., Guyatt, G., Albers, G. W., Harrington, R., & Schünemann, H. J. (2008) · Chest · doi:10.1378/chest.08-0652 · Cited by 297
Graduated compression stockings in the prevention of venous thromboembolism
Agu, O., Hamilton, G., & Baker, D. (1999) · Journal of British Surgery · doi:10.1046/j.1365-2168.1999.01195.x · Cited by 296 · cited 1×
“Agu et al have shown that these mechanical methods reduce postoperative venous thrombosis.(65) A Cochrane review showed a reduction of”
COLLINS, R., SCRIMGEOUR, A., YUSUF, S., PETO, R., & Roizen, M. F. (1989) · Survey of Anesthesiology · doi:10.1097/00132586-198902000-00032 · Cited by 294 · cited 4×
“78 It has a far greater effect on inhibition of factor Xa and a lesser effect on antithrombin III by inhibiting thrombin to a lesser extent than UFH.”
InfluentialROSENDAAL, F. R., & REITSMA, P. H. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03394.x · Cited by 291 · cited 1×
“Genetic risk factors can be divided into strong, moderate, and weak factors.(34) Strong factors are deficiencies of antithrombin, protein C and protein S.”
Fraser, D. G. W., Moody, A. R., Morgan, P. S., Martel, A. L., & Davidson, I. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-2-200201150-00006 · Cited by 280 · cited 2×
“This investigative modality has high sensitivity in detecting calf and pelvic DVTs, 62 and upper extremity venous thromboses.”
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., Greer, I., & Hirsh, J. (2001) · Chest · doi:10.1378/chest.119.1_suppl.122s · Cited by 280
Weitz, J. I., Hirsh, J., & Samama, M. M. (2008) · Chest · doi:10.1378/chest.08-0673 · Cited by 262 · cited 3×
“It has a half-life of 8 hours after single-dose administration and up to 17 hours after multiple doses with plasma levels that peak at 2 hours.(81) The drug is excreted largely unchanged via the kidneys.”
InfluentialHull, R. D. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.22.2562 · Cited by 261
The Fibrinolytic Effects of Intermittent Pneumatic Compression: Mechanism of Enhanced Fibrinolysis
Comerota, A. J., Chouhan, V., Harada, R. N., Sun, L., Hosking, J., Veermansunemi, R., Comerota, A. J., Schlappy, D., & Rao, A. K. (1997) · Annals of Surgery · doi:10.1097/00000658-199709000-00010 · Cited by 249 · cited 1×
“There is a theoretical risk of fibrinolysis and clot dislodgement.(70) Leg wrappings and stockings with no pressure gradient are ineffective in the prevention of DVT.”
Goldenberg, N. A., Knapp-Clevenger, R., & Manco-Johnson, M. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040161 · Cited by 237 · cited 1×
“Elevated D-dimer was found to be predictive of poor outcome (persistent thrombosis, recurrence or post-thrombotic syndrome) in children with an acute thrombotic event.(49) False negative D-dimer results have been noted after heparin use; hence it has been recommended that D-dimer assay should be done prior to administ…”
Powers, P. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040013003 · Cited by 214 · cited 1×
“Some studies on the use of aspirin as prophylactic agent for DVT have shown some degree of protection against VTE in hospitalized patients, 91,92 while other studies have either shown no benefit, 93,94 or have proven to be less effective to other thromboprophylactic agents.”
Ultrasonography and Diagnosis of Venous Thromboembolism
Zierler, B. K. (2004) · Circulation · doi:10.1161/01.cir.0000122870.22669.4a · Cited by 213 · cited 1×
“Compression ultrasound is typically performed on the proximal deep veins, specifically the common femoral, femoral, and popliteal veins, whereas a combination of duplex ultrasound and color duplex is more often used to investigate the calf and iliac veins.(52) The major ultrasonographic criterion for detecting venous…”
Risk factors for venous thrombosis: prevalence, risk, and interaction.
Rosendaal, F. R. (1997) · PubMed · Cited by 211
Prophylaxis for Thromboembolism in Hospitalized Medical Patients
Francis, C. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp067264 · Cited by 195 · cited 1×
“These includes patients with active or recent gastrointestinal bleeding, patients with hemorrhagic stroke, and those with hemostatic defects such as severe thrombocytopenia.(69) It is contraindicated in patients with evidence of leg ischemia due to peripheral vascular disease.”
McKenna, R., Galante, J. O., Bachmann, F., Wallace, D. L., Kaushal, P. S., & Meredith, P. (1980) · BMJ · doi:10.1136/bmj.280.6213.514 · Cited by 192 · cited 1×
“Some studies on the use of aspirin as prophylactic agent for DVT have shown some degree of protection against VTE in hospitalized patients, 91,92 while other studies have either shown no benefit, 93,94 or have proven to be less effective to other thromboprophylactic agents.”
Elastic compression stockings for prevention of deep vein thrombosis
Amaragiri, S. V., & Lees, T. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001484 · Cited by 186 · cited 1×
“VTE by about 50% with the use of graduated compression stockings.(66) Intermittent pneumatic compression, in addition to preventing venous thrombosis, has been shown to reduce plasminogen activator inhibitor-1, thereby increasing endogenous fibrinolytic activity.”
Stratton, M. A., Anderson, F. A., Bussey, H. I., Caprini, J., Comerota, A., Haines, S. T., Hawkins, D. W., O'Connell, M. B., Smith, R. C., & Stringer, K. A. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.3.334 · Cited by 184
How we diagnose and treat deep vein thrombosis
Hirsh, J., & Lee, A. Y. Y. (2002) · Blood · doi:10.1182/blood.v99.9.3102 · Cited by 179 · cited 1×
“venous ultrasonography Venous ultrasonography is the investigation of choice in patients stratified as DVT likely.(50) It is noninvasive, safe, available, and relatively inexpensive.”
Kakkos, S. K., Caprini, J. A., Geroulakos, G., Nicolaides, A. N., Stansby, G. P., & Reddy, D. J. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2008.11.033 · Cited by 172
Natural History of Venous Thromboembolism
Colwell, C. W., & Hardwick, M. E. (2004) · Techniques in Orthopaedics · doi:10.1097/01.bto.0000145146.68315.22 · Cited by 172
Biomarkers and Venous Thromboembolism
Pabinger, I., & Ay, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182188 · Cited by 158 · cited 1×
“It reflects a global activation of blood coagulation and fibrinolysis.(38) It is the best recognized biomarker for the initial assessment of suspected VTE.”
The Wells Rule Does Not Adequately Rule Out Deep Venous Thrombosis in Primary Care Patients
Oudega, R., Hoes, A. W., & Moons, K. G. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-2-200507190-00008 · Cited by 152 · cited 1×
“Though this model has been used for both primary care patients and secondary settings, there is no doubt that it does not guarantee accurate estimation of risk in primary care patients in whom DVT is suspected.(35) Jo ur na l o f B lo od M ed ic in e do w nl oa de d fr om h ttp s: //w w w .”
Leonardi, M. J., McGory, M. L., & Ko, C. Y. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.8.790 · Cited by 151 · cited 4×
“78 It has a far greater effect on inhibition of factor Xa and a lesser effect on antithrombin III by inhibiting thrombin to a lesser extent than UFH.”
InfluentialLong-term outcomes after deep vein thrombosis: Postphlebitic syndrome and quality of life
Kahn, S. R., Solymoss, S., Lamping, D. L., & Abenhaim, L. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.06419.x · Cited by 148 · cited 2×
“Daily use of elastic compression stockings after proximal DVT reduced the incidence of postphlebitis syndrome by 50%.(20) Other mechanical means in both medical and surgical patients include ambulation and exercises involving foot extension.”
Kahn, S. R. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.21.2315 · Cited by 141
Valves of the deep venous system: an overlooked risk factor
Brooks, E. G., Trotman, W., Wadsworth, M. P., Taatjes, D. J., Evans, M. F., Ittleman, F. P., CALLAS, P. W., Esmon, C. T., & Bovill, E. G. (2009) · Blood · doi:10.1182/blood-2009-03-209981 · Cited by 134 · cited 1×
“This means an upregulation of anticoagulants (EPCR, TM) and a downregulation of procoagulant (vWF) properties of the valvular sinus endothelium.(17) Thrombus is composed predominantly of fibrin and red cells (red or static thrombus).”
How we manage venous thromboembolism during pregnancy
Bates, S. M., & Ginsberg, J. S. (2002) · Blood · doi:10.1182/blood-2002-03-0965 · Cited by 131 · cited 1×
“However the drug is safe during lactation as it does not accumulate in the breast milk to a substantial extent.(89) Unlike warfarin, heparin is safe and it is recommended both in pregnancy and lactation.”
Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism
Brotman, D. J., Segal, J. B., Jani, J. T., Petty, B. G., & Kickler, T. S. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01520-6 · Cited by 121 · cited 1×
“False positive D-dimer results have been noted in inflammation, 41 pregnancy, 42 malignancy, 43 and the elderly.”
Clayton, T. C., Gaskin, M., & Meade, T. W. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr012 · Cited by 120 · cited 1×
“They demonstrated an increased risk of DVT in the month following infection and PE in 3 months following infection, both persisting up to a year.(32) In the pediatric age group, the most important triggering risk factors for development of thromboembolism are the presence of central venous lines, cancer, and chemother…”
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis
van Aken, B. E., Reitsma, P. H., & Rosendaal, F. R. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03245.x · Cited by 119
Deep venous thrombosis of extremities: role of MR imaging in the diagnosis.
Erdman, W. A., Jayson, H. T., Redman, H. C., Miller, G. L., Parkey, R. W., & Peshock, R. M. (1990) · Radiology · doi:10.1148/radiology.174.2.2404315 · Cited by 116 · cited 1×
“Magnetic resonance imaging (MRi) This investigative modality has high sensitivity in detecting calf and pelvic DVTs,(62) and upper extremity venous thromboses.(63) It is also relevant in ruling out differential diagnoses in patients suspected of DVT.”
Nunnelee, J. D. (2010) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2010.03.002 · Cited by 111
Kakkos, S. K., Caprini, J. A., Geroulakos, G., Nicolaides, A. N., Stansby, G., & Reddy, D. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005258.pub2 · Cited by 110 · cited 1×
“This is recommended especially for high-risk patients.(68) A mechanical method of DVT prophylaxis is indicated in patients at high risk of bleeding with anticoagulation prophylaxis.”
Gent, M., Hirsh, J., Ginsberg, J., Powers, P., Levine, M. N., Geerts, W. H., Jay, R. M., Leclerc, J. E., Neemeh, J. A., & Turpie, A. G. G. (1996) · Circulation · doi:10.1161/01.cir.93.1.80 · Cited by 109 · cited 1×
“Some studies on the use of aspirin as prophylactic agent for DVT have shown some degree of protection against VTE in hospitalized patients,(91,92) while other studies have either shown no benefit,(93,94) or have proven to be less effective to other thromboprophylactic agents.(95,96) The duration of thromboprophylaxis…”
D-dimer concentrations during normal pregnancy, as measured by ELISA
Francalanci, I., Comeglio, P., Liotta, A. A., Cellai, A. P., Fedi, S., Parretti, E., Mello, G., Prisco, D., & Abbate, R. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00073-z · Cited by 109 · cited 1×
“48 Elevated D-dimer was found to be predictive of poor outcome (persistent thrombosis, recurrence or post-thrombotic syndrome) in children with an acute thrombotic event.”
Morris, R., & Woodcock, J. P. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181b5d61c · Cited by 108 · cited 2×
“However no meaningful difference in performance between GCS and IPC was demonstrated by Morris and Woodcock.(74)”
Patterson, B. O., Hinchliffe, R. J., Loftus, I. M., THOMPSON, M. M., & Holt, P. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200766 · Cited by 98 · cited 3×
“Current evidence suggests that CDT can reduce clot burden and DVT recurrence and consequently prevent the formation of post-thrombotic syndrome compared with systemic anticoagulation.(106) Pharmacomechanical CDT is now routinely used in some centers for the treatment of acute iliofemoral DVT.”
InfluentialChin, P., Amin, M., Yang, K., Yeo, S. J., & Lo, N. N. (2009) · Journal of orthopaedic surgery · doi:10.1177/230949900901700101 · Cited by 89 · cited 2×
“Chin et al compared the efficacy and safety of different modes of thromboembolic prophylaxis (IPC, GCS, and enoxaparin) for elective total knee arthroplasty (TKA) in Asian patient and recommended IPC as the preferred method of thromboprophylaxis for TKA.(73) However no meaningful difference in performance between GCS…”
Aspirin in the prevention and treatment of venous thromboembolism
Hovens, M. M. C., Snoep, J. D., Tamsma, J. T., & Huisman, M. V. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01928.x · Cited by 87
Oudega, R., Moons, K. G. M., & Hoes, A. W. (2004) · Family Practice · doi:10.1093/fampra/cmh718 · Cited by 77
The Role of Thrombolysis in the Clinical Management of Deep Vein Thrombosis
Popuri, R., & Vedantham, S. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213413 · Cited by 67 · cited 1×
“Pharmacomechanical CDT is now routinely used in some centers for the treatment of acute iliofemoral DVT.(107) Appropriate indications may include younger individuals with acute proximal thromboses, a long life expectancy, and relatively few comorbidities.”
Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation
Masotti, L., Ray, P., Righini, M., Gal, G. L., Antonelli, F., Landini, G., Cappelli, R., Prisco, D., & Rottoli, P. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2605 · Cited by 65 · cited 1×
“Clinical usefulness of the measurement of D-dimer has been shown to decrease with age.(45) The use of age-dependent cut-off values of D-dimer assays is still a matter of controversy.”
Hemodynamic Disorders, Thromboembolic Disease, and Shock
Mitchell, R. N. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50009-2 · Cited by 55
Acquired Risk Factors for Venous Thromboembolism in Medical Patients
Prandoni, P. (2005) · Hematology · doi:10.1182/asheducation-2005.1.458 · Cited by 52 · cited 1×
“Other acquired factors that have recently been associated with increased risk of VTE disorders include persistent elevation of D-dimer and atherosclerotic disease.(27) Oral contraceptive pills, especially those that contain third-generation progestins increase the risk of VTE.”
Lower limb venous dynamics in pregnant women.
Rw, I., Ueland, K., & Folse, R. (1971) · PubMed · Cited by 51
DVT and pulmonary embolism: Part II. Treatment and prevention.
Ramzi, D. W., & Leeper, K. V. (2004) · PubMed · Cited by 45
Eichinger, S. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083822 · Cited by 42
Noninvasive Diagnosis of Deep Vein Thrombosis
Landefeld, C. S. (2008) · JAMA · doi:10.1001/jama.300.14.1696 · Cited by 42
Powers, P. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.4.771 · Cited by 38
LOWER LIMB VENOUS DYNAMICS IN PREGNANT WOMEN
Ikard, R. W., Ueland, K., & Folse, R. (1971) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197107000-00003 · Cited by 33 · cited 1×
“This may be due to compression of the left iliac vein by the right iliac artery (May–Thurner syndrome).(24) Phlegmasia alba dolens is characterized by edema, pain, and blanching without cyanosis while phlegmasia cerulea dolens is characterized by these features in addition to cyanosis, which characteristically progres…”
Acquired Risk Factors of Venous Thromboembolism in Medical Patients
Prandoni, P. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093554 · Cited by 28
Rivaroxaban: An Oral Direct Factor Xa Inhibitor for the Prevention of Thromboembolism
Chen, T., & Lam, S. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181aa2154 · Cited by 16 · cited 1×
“The results of RECORD phase III trials have also shown that rivaroxaban 10 mg once daily is superior to the LMWH enoxaparin, when used for prophylaxis of VTE in orthopedic surgeries.(86) The drug also has the major advantages of once daily oral dosing and no required laboratory monitoring.”
Dabigatran etexilate: advances in anticoagulation therapy
Dahl, O. E., & Huisman, M. V. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.67 · Cited by 8 · cited 1×
“The RE-COVER trial compared dabigatran etexilate with warfarin for 6 months in patients with acute VTE; dabigatran was as effective as warfarin in preventing recurrent VTE, with comparable major bleeding and significantly lower total bleeding rates.(82,83) Another study (The RE-NOVATE II trial) compared the efficacy a…”
Cited by
Fibrinolysis and Inflammation in Venous Thrombus Resolution
Mukhopadhyay, S., Johnson, T. A., Duru, N., Buzza, M. S., Pawar, N. R., Sarkar, R., & Antalis, T. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01348 · Cited by 164
Guillen-Grima, F., Guillen-Aguinaga, S., Guillen-Aguinaga, L., Alas-Brun, R., Onambele, L., Ortega, W., Montejo, R., Aguinaga-Ontoso, E., Barach, P., & Aguinaga-Ontoso, I. (2023) · Clinics and Practice · doi:10.3390/clinpract13060130 · Cited by 72
“If a patient undergoes an unnecessary phlebography based on this incorrect advice, it could lead to potential complications such as allergic reactions to contrast dye, phlebitis, or even more severe complications like venous thromboembolism [104,105].”
Background
Metadata
- Authors
- Kesieme, & Kesieme
- Venue
- Journal of Blood Medicine
- Publisher
- Informa UK Limited
- Published
- 2011-04
- Volume
- 2
- Pages
- 59
- ISSN
- 1179-2736 (ISSN-L)
- OpenAlex
- W2008872411
- Cited by
- 208
- References
- 99
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.